Insider Cluster (5 insiders) ·Filed Mar 16, 2026

ORKA

Oruka Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $147K total
Actionable Insight ▼ Bearish

Monitor for upcoming earnings, clinical trial updates, or potential downgrades; coordinated C-suite selling may signal lack of confidence ahead of negative news. Watch for follow-up filings or increased trading volume.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ORKA ▲ +53.44% at T+60d
SHORT call ✗ call lost -53.44% · α vs SPY -42.95% · entry $41.75 → $64.06
Entry anchored
Mar 13, 03:59 PM ET
via exchange tick
T+1d
-1.05%
call +1.05% · α +1.33%
$41.31
settled 7mo ago
T+5d
-0.46%
call +0.46% · α -1.59%
$41.56
settled 7mo ago
T+20d
+60.62%
call -60.62% · α -56.84%
$67.06
settled 6mo ago
T+60d
+53.44%
call -53.44% · α -42.95%
$64.06
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Multiple Oruka Therapeutics executives, including the CEO, CMO, and COO, sold shares in a coordinated cluster over a single day, totaling $248.8K in open-market sales. The CMO also exercised derivative securities, though most of those transactions were non-cash. The total value represents a small fraction of the company's $2.1B market cap.

Key Financial Metrics

Direction
selling
Total Value
$248.7K
Insiders
5

Key Facts

  • CEO Klein Lawrence Otto sold $71,407.7 worth of shares in an open-market transaction.
  • CMO Goncalves Joana sold $117,158.68 of stock and exercised derivative securities (total nominal value $23,940, remainder non-cash).
  • COO Sandler Laura Lee sold $24,780 in shares; CFO Agarwal Arjun sold $16,313.5.
  • All transactions occurred on 2026-03-16, indicating a coordinated timing event.
  • Total open-market sales by insiders: $248,732.78 across four executives.

Financial Impact

$248.7K in net insider selling over one day

insider sentimentshareholder dilution risk (neutral)market perception

Risk Factors

  • Insider selling could precede negative clinical or financial news.
  • Perception risk: multiple senior executives exiting positions may spook retail investors.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-ORKA-1773778049710
26 reports for ORKA
Performance horizon
100% Hit rate 10 of 10 directional calls best @ T+60▲ +80.05%Jun 1, 2026
Filters
Rows
Reports for ORKA — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$93.55 $89.93▼ −3.87%▼ −6.44%$84.38 (−9.80%)
Sep 1, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$91.63 $91.65▼ −0.02%▼ −0.98%$84.38 (+7.91%)
Aug 28, 2026
5w ago
EFFECT
BEARISH ★ 6/10
$91.15 $92.51▼ −1.50%▼ −1.39%$84.38 (+7.42%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.08 $101.82▼ −9.96%▼ −9.76%$84.38 (−25.38%)
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 6/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Aug 9, 2026
7w ago
Institutional Cluster
BULLISH ★ 7/10
$105.14 $112.66▲ +7.15%▲ +7.20%$84.38 (−19.75%)
Jul 15, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.04 $91.95▲ +10.73%▲ +12.40%$84.38 (+1.61%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 5/10
$85.21 $88.27▲ +3.59%▲ +2.66%$84.38 (−0.97%)
Jun 22, 2026
14w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.40 $92.49▲ +10.90%▲ +9.89%$84.38 (+1.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 3h 54m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 17, 2026